Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients

Transplant Proc. 1997 Nov;29(7):2955-7. doi: 10.1016/s0041-1345(97)00743-4.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Drug Resistance
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Graft Rejection / drug therapy*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Male
  • Muromonab-CD3 / therapeutic use*
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use*
  • Time Factors

Substances

  • Immunosuppressive Agents
  • Muromonab-CD3
  • Tacrolimus